16 E7 oncoprotein. Proc Natl Acad Sci USA 96(4): 1291296. 14. Stet A, et al. (2007) Nuclear translocation on the tumor marker pyruvate kinase M2 induces programmed cell death. Cancer Res 67(4):1602608. 15. Boxer MB, et al. (2010) Evaluation of substituted N,N’-diarylsulfonamides as activators from the tumor cell particular M2 isoform of pyruvate kinase. J Med Chem 53(three): 1048055. 16. Jiang JK, et al. (2010) Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of your tumor cell precise M2 isoform of pyruvate kinase. Bioorg Med Chem Lett 20(11):3387393. 17. Vander Heiden MG, et al. (2010) Identification of compact molecule inhibitors of pyruvate kinase M2. Biochem Pharmacol 79(eight):1118124. 18. Flory W, Peczon BD, Koeppe RE, Spivey HO (1974) Kinetic properties of rat liver pyruvate kinase at cellular concentrations of enzyme, substrates and modifiers. Biochem J 141(1):12731. 19. Burton RL, Chen S, Xu XL, Grant GA (2009) Transient kinetic analysis on the interaction of L-serine with Escherichia coli D-3-phosphoglycerate dehydrogenase reveals the mechanism of V-type regulation and the order of effector binding. Biochemistry 48(51):122422251. 20. Kato H, Fukuda T, Parkison C, McPhie P, Cheng SY (1989) Cytosolic thyroid hormonebinding protein is often a monomer of pyruvate kinase. Proc Natl Acad Sci USA 86(20): 7861865.21. Ashizawa K, Willingham MC, Liang CM, Cheng SY (1991) In vivo regulation of monomer-tetramer conversion of pyruvate kinase subtype M2 by glucose is mediated by means of fructose 1,6-bisphosphate. J Biol Chem 266(25):168426846. 22. Ashizawa K, McPhie P, Lin KH, Cheng SY (1991) An in vitro novel mechanism of regulating the activity of pyruvate kinase M2 by thyroid hormone and fructose 1, 6bisphosphate.HKOH-1r web Biochemistry 30(29):7105111. 23. Larsen TM, Benning MM, Rayment I, Reed GH (1998) Structure of your bis(Mg2+)-ATPoxalate complicated from the rabbit muscle pyruvate kinase at 2.1 A resolution: ATP binding over a barrel. Biochemistry 37(18):6247255. 24. Morgan HP, et al. (2010) Allosteric mechanism of pyruvate kinase from Leishmania mexicana utilizes a rock and lock model. J Biol Chem 285(17):128922898. 25. Consler TG, Woodard SH, Lee JC (1989) Effects of key sequence differences on the worldwide structure and function of an enzyme: A study of pyruvate kinase isozymes.Zaprinast Cancer Biochemistry 28(22):8756764.PMID:23415682 26. Williams R, Holyoak T, McDonald G, Gui C, Fenton AW (2006) Differentiating a ligand’s chemical requirements for allosteric interactions from those for protein binding. Phenylalanine inhibition of pyruvate kinase. Biochemistry 45(17):5421429. 27. Kumar Y, et al. (2010) In vivo factors influencing tumour M2-pyruvate kinase level in human pancreatic cancer cell lines. Tumour Biol 31(two):697. 28. Mazurek S, Eigenbrodt E (2003) The tumor metabolome. Anticancer Res 23(2A): 1149154. 29. Eigenbrodt E, Reinacher M, Scheefers-Borchel U, Scheefers H, Friis R (1992) Double function for pyruvate kinase form M2 within the expansion of phosphometabolite pools discovered in tumor cells. Crit Rev Oncog 3(1-2):9115. 30. Zhou CF, et al. (2012) Pyruvate kinase form M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cells. IUBMB Life 64(9):77582. 31. Hardin CD, Roberts TM (1994) Metabolism of exogenously applied fructose 1,6bisphosphate in hypoxic vascular smooth muscle. Am J Physiol 267(6 Pt 2):H2325 2332. 32. Chaneton B, et al. (2012) Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature 491(7424):45862. three.